AlphaFold predicted structure
MAT1A · Q00266

Mean pLDDT
96.6/ 100
Very high
395 residues
Confidence breakdown
- Very high(≥ 90)96%
- Confident(70–90)1%
- Low(50–70)1%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methionine adenosyltransferase 1A
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BOTH monoallelic and biallelic, autosomal or pseudoautosomalLikely inborn error of metabolism
BOTH monoallelic and biallelic, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalAdult onset dystonia, chorea or related movement disorder
Adult onset neurodegenerative disorder
UnknownChildhood onset dystonia, chorea or related movement disorder
Unknown+3 more panels — install the extension to see the full list inline on any page.
methionine adenosyltransferase deficiency
Brain demyelination due to methionine adenosyltransferase deficiency
hepatic methionine adenosyltransferase deficiency
Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency
neurodegenerative disease
glaucoma
open-angle glaucoma
hereditary disease
hepatocellular carcinoma
metabolic dysfunction-associated steatohepatitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
S-adenosylmethionine synthase isoform type-1
Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate
MAT1A · Q00266

Mean pLDDT
96.6/ 100
Very high
395 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0